The Heart

The Heart Promote Cardiovascular Education and Research
(1)

🔴Amiodarone-induced hypothyroidism (AIH) requires careful monitoring! 🩺⤵️✔️ Check TSH & free T4 before starting✔️ Monito...
12/09/2025

🔴Amiodarone-induced hypothyroidism (AIH) requires careful monitoring! 🩺⤵️

✔️ Check TSH & free T4 before starting
✔️ Monitor every 3-6 months
✔️ Treat with levothyroxine if needed
✔️ Continue amiodarone unless severe

Cardiac patients need extra care! 💙

🔴Pacing induced cardiomyopathy⤵️ 🔹🩺 Clinical Pearls:1) High RV Pacing Burden = High Risk▪︎A pacing burden >20–40% is the...
12/09/2025

🔴Pacing induced cardiomyopathy⤵️ 🔹

🩺 Clinical Pearls:

1) High RV Pacing Burden = High Risk
▪︎A pacing burden >20–40% is the strongest predictor of PICM.
▪︎Monitor patients with pacemakers closely if RV pacing is frequent.

2) PICM Is Often Reversible
▪︎Upgrading to Cardiac Resynchronization Therapy (CRT) can restore LVEF and improve symptoms in most patients.

3) Dyssynchrony Is the Culprit

RV apical pacing mimics a LBBB pattern, delaying LV activation and causing harmful ventricular dyssynchrony.

4) Baseline and Serial Echocardiography Are Key

Assess LVEF before and after pacemaker implantation in high-risk patients to detect early dysfunction.

5) Consider Physiological Pacing Early

His-bundle or left bundle branch area pacing (LBBAP) are more physiological and reduce PICM risk compared to RV apical pacing.

6) Preventive Strategy

In patients likely to be pacemaker-dependent (e.g. AV block), consider CRT or physiological pacing upfront rather than RV-only pacing!!


🔴A Clinical Approach to Lactic Acidosis⤵️    🔹🩸🩸🩸
12/09/2025

🔴A Clinical Approach to Lactic Acidosis⤵️

🔹🩸🩸🩸

🔴Anticoagulation in CKD/ESRD: ⤵️  🔹CKD/ESRD adds significant complexity to anticoagulation management, mainly due to⬆️bl...
12/09/2025

🔴Anticoagulation in CKD/ESRD: ⤵️

🔹CKD/ESRD adds significant complexity to anticoagulation management, mainly due to⬆️bleeding risk.

🔹What about the new kid on the block, FXI inhibitors,in CKD/ESRD?

🔹Anticoagulation selection and dosing in CKD/ESRD: PK of AC in RRT

🔹Anticoagulation selection and dosing in CKD/ESRD

🔹AC Dosing in VTE or A-Fib in CKD/ESRD

🔴Heparin - Unfractionated Heparin (UFH)🫀⤵️                 🐦‍🔥🐦‍🔥🐦‍🔥               🔹💉 UFH Overview:Binds antithrombin II...
12/09/2025

🔴Heparin - Unfractionated Heparin (UFH)🫀⤵️
🐦‍🔥🐦‍🔥🐦‍🔥
🔹💉 UFH Overview:
Binds antithrombin III → inhibits thrombin (IIa) & Xa
IV or SQ, short t½, reversible
Indications: VTE tx/prophylaxis, ACS, AFib, ECMO, dialysis, procedures, pregnancy 🤰



📏 UFH Dosing Protocols:

1️⃣ VTE Treatment Protocols:

A. Weight-Based (High Dose / Full Anticoagulation):
•Bolus: 80–100 units/kg IV
•Infusion: 15–18 units/kg/hr
•Target aPTT: 1.5–2.5× control (monitor q6h until stable)

B. Low Dose Protocol (Renal/Hemorrhagic Risk or Elderly):
•Bolus: 60–70 units/kg IV
•Infusion: 12 units/kg/hr
•Titrate to same aPTT target

C. Fixed Dose Protocol:
•Bolus: 5000 units IV
•Infusion: 1000 units/hr
•Useful when weight unknown or rapid start needed
•Adjust per aPTT



2️⃣ VTE Prophylaxis (Low Dose SQ):
•5000 units SQ q8–12h
•No lab monitoring needed
•Use in hospitalized, immobile, or postop pts



🛑 Antidote: Protamine Sulfate
•1 mg neutralizes ~100 units UFH
•Max: 50 mg IV over 10–15 min
•Monitor for hypotension, anaphylaxis



⚠️ Side Effects:
•Bleeding 🚨
•HIT (Type II) 🧪
•Osteoporosis (long-term) 🦴
•Hyperkalemia
•Transaminitis
•Injection site bruising



🧠 Pearls:
•No renal dose adjustment
•Monitor aPTT or anti-Xa
•If HIT suspected → STOP heparin → start argatroban/bivalirudin
•Use IV route for rapid on/off (e.g., surgery)
•SQ low dose safe for prophylaxis, even in ESRD


🔴State of the Art in Left Atrial Appendage Occlusion⤵️State-Of-The-Art     🔹The utility of left atrial appendage occlusi...
12/09/2025

🔴State of the Art in Left Atrial Appendage Occlusion⤵️State-Of-The-Art

🔹The utility of left atrial appendage occlusion as a therapy for stroke prevention in patients with nonvalvular is the focus of a State-of-the-Art Review published in .

🔹Read more: bit.ly/4g0amK6

🔴 𝘿𝙤𝙨𝙖𝙜𝙚 𝙤𝙛 𝙈𝙚𝙩𝙛𝙤𝙧𝙢𝙞𝙣 𝙖𝙣𝙙 𝙎𝙂𝙇𝙏2𝙞 𝙞𝙣 𝘾𝙆𝘿 𝙥𝙖𝙩𝙞𝙚𝙣𝙩𝙨 𝙬𝙞𝙩𝙝 𝙏2𝘿𝙈✅SGLT2i along with Metformin remains the first line oral drugs...
12/09/2025

🔴 𝘿𝙤𝙨𝙖𝙜𝙚 𝙤𝙛 𝙈𝙚𝙩𝙛𝙤𝙧𝙢𝙞𝙣 𝙖𝙣𝙙 𝙎𝙂𝙇𝙏2𝙞 𝙞𝙣 𝘾𝙆𝘿 𝙥𝙖𝙩𝙞𝙚𝙣𝙩𝙨 𝙬𝙞𝙩𝙝 𝙏2𝘿𝙈

✅SGLT2i along with Metformin remains the first line oral drugs for management of T2DM with CKD.

✅If a patient on CKD is already on metformin, it can be continued at a maximum dose of 1gm/day If eGFR is >30. Metformin is contraindicated in eGFR 45 in CKD patients.

✅SGLT2i should be initiated when eGFR is >20 and continued, as tolerated, until dialysis or transplantation is initiated.

✅A reversible decrease in the eGFR with commencement of SGLT2i treatment may occur and is generally not an indication to discontinue therapy.

✅Once initiated SGLT2i be continued as long as tolerated, even if eGFR falls below, until kidney replacement therapy is initiated.

✅The recommendation for SGLT2i is for kidney and cardiovascular protection and SGLT2i have been shown to have safety and benefit in CKD patients, even for those without T2D.

✅Source: Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence.

⭕️This guideline issues a strong recommendation for use of an SGLT2i in the treatment of people with T2D and CKD, positioning SGLT2i as first-line drug therapy to prevent CKD progression and cardiovascular events, regardless of glycemia.
https://onlinelibrary.wiley.com/doi/full/10.1111/nep.14167 #:~:text=prior%20to%20treatment.-,There%20is%20no%20convincing%20evidence%20that%20the%20use%20of%20SGLT%2D2,not%20be%20a%20deterrent%20to%20initiating%20SGLT%2D2%20inhibitor%20therapy%2C%20specifically%3A,-A%20urine%20culture

Address

Addis Ababa
4162

Opening Hours

Monday 08:00 - 22:00
Tuesday 08:00 - 22:00
Wednesday 08:00 - 22:00
Thursday 08:00 - 22:00
Friday 08:00 - 22:00
Saturday 09:00 - 17:00
Sunday 09:00 - 17:00

Telephone

+251964643565

Website

Alerts

Be the first to know and let us send you an email when The Heart posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to The Heart:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram